|
|
|
|
| LEADER |
02789nam a22005175i 4500 |
| 001 |
978-94-007-0884-6 |
| 003 |
DE-He213 |
| 005 |
20151103131054.0 |
| 007 |
cr nn 008mamaa |
| 008 |
110913s2012 ne | s |||| 0|eng d |
| 020 |
|
|
|a 9789400708846
|9 978-94-007-0884-6
|
| 024 |
7 |
|
|a 10.1007/978-94-007-0884-6
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a R-RZ
|
| 072 |
|
7 |
|a MBGR
|2 bicssc
|
| 072 |
|
7 |
|a MED000000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 610
|2 23
|
| 245 |
1 |
0 |
|a Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009
|h [electronic resource] /
|c edited by Nigel Jenkins, Niall Barron, Paula Alves.
|
| 264 |
|
1 |
|a Dordrecht :
|b Springer Netherlands,
|c 2012.
|
| 300 |
|
|
|a XLIV, 756 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a ESACT Proceedings ;
|v 5
|
| 505 |
0 |
|
|a 1 Synthetic and Molecular Biology -- 2 Stem Cells -- 3 Tissue Engineering -- 4a Advances in Bioprocessing -- 4b Advances in Bioprocessing -- 5 Biotherapeutics -- 6 Novel Vaccines and Virology -- 7 WorkShops -- Index.
|
| 520 |
|
|
|a The 21st ESACT meeting – ‘Cellular Solutions for Clinical Challenges’ outlined the novel capabilities of animal cell technology to move towards the clinic. The highly successful meeting was attended by a record number of researchers and engineers interested in all aspects of animal cell technology. The meeting included sessions on Stem Cells, Tissue Engineering, Advances in Bioprocessing, Biotherapeutics, Novel Vaccines and Virology and Advances in Synthetic and Molecular Biology. The meeting was supported by an array of exceptional invited speakers from around the world whose contributions complemented the emerging technologies and the challenges facing the clinical application of animal cell culture and technologies. The proceedings here include the short papers, adding to the wealth of knowledge gained from previous ESACT meetings.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Biotechnology.
|
| 650 |
|
0 |
|a Life sciences.
|
| 650 |
|
0 |
|a Cell biology.
|
| 650 |
1 |
4 |
|a Biomedicine.
|
| 650 |
2 |
4 |
|a Biomedicine general.
|
| 650 |
2 |
4 |
|a Cell Biology.
|
| 650 |
2 |
4 |
|a Life Sciences, general.
|
| 650 |
2 |
4 |
|a Biotechnology.
|
| 700 |
1 |
|
|a Jenkins, Nigel.
|e editor.
|
| 700 |
1 |
|
|a Barron, Niall.
|e editor.
|
| 700 |
1 |
|
|a Alves, Paula.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9789400708839
|
| 830 |
|
0 |
|a ESACT Proceedings ;
|v 5
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-94-007-0884-6
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
